| Investigator |
Title |
Sponsor |
ID |
Dates |
Amount |
| Laura E Agresta, MD |
Investigating CD244 as a New Therapeutic Target for Immune Checkpoint Inhibition |
Cancer Free Kids |
CFK |
7/1/2018 - 12/31/2019 |
$36,000 |
| Allison L Bartlett, MD |
Serotonin: A Novel Target in Fanconi Anemia |
Fanconi Anemia Research Fund |
2018FARF |
10/28/2018 - 10/27/2019 |
$10,000 |
| Adrienne Hammill, MD |
Brain Vascular Malformation Consortium: Predictor's of Clinical Course per Patient |
The Regents of the Univ of California (National Institutes of Health (NIH)) |
8415 |
8/1/2018 - 7/31/2019 |
$32,286 |
| LaQuita M Jones DO |
Efficacy of novel FLT3 inhibitor in tyrosine kinase domain FLT3 ITD (+) AML |
St. Baldrick's Foundation |
524748 |
7/1/2018 - 6/30/2019 |
$81,175 |
| LaQuita M Jones DO |
A Novel Therapeutic Strategy for Refractory and Relapsed FLT3-mutant AML |
Cancer Free Kids |
CFK |
7/1/2018 - 6/30/2020 |
$50,000 |
| Patrick McGann, MD-MS |
Maximizing Fetal Hemoglobin Responses to Hydroxyurea using Precision Medicine |
Doris Duke Charitable Foundation |
2017090 |
9/1/2018 - 8/31/2019 |
$330,000 |
| Eric Mullins, MD |
Mechanisms linking Hemostatic Factors and Neuroinflammatory Disease |
National Institutes of Health (NIH) |
R01NS107258 |
3/1/2019 - 2/29/2020 |
$412,354 |
| Omar Y. Niss, MD |
Community Health Workers and mHealth for Sickle Cell Disease |
Children's Hospital of Philadelphia (Patient-Centered Outcome Research Inst.) |
4261420324 |
3/1/2018 - 2/28/2019 |
$245,627 |
| Joseph S Palumbo, MD |
Hemostatic Factors Drive Prostate Cancer Pathogenesis |
National Institutes of Health (NIH) |
R01CA193678 |
4/15/2019 - 3/31/2020 |
$346,144 |
| Joseph S Palumbo, MD |
Coagulation factors as modifiers of the colon cancer microenvironment |
National Institutes of Health (NIH) |
R01CA204058 |
4/1/2019 - 3/31/2020 |
$346,144 |
| Charles T Quinn, MD |
DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment |
Medical University of South Carolina (National Institutes of Health (NIH)) |
MUSC17-068-8C868 |
7/1/2018 - 12/31/2018 |
$28,531 |
| Lisa M Shook |
Cincinnati Sickle Cell Project |
Ohio Department of Health |
0310011SK1017 |
7/1/2018 - 6/30/2019 |
$125,956 |
| Lisa M Shook |
Sickle Treatment and Outcomes Research in the Midwest |
National Institutes of Health (NIH) |
U1EMC27863 |
9/1/2018 - 8/31/2019 |
$521,154 |
| Luke R Smart, MD |
Bedside Expedited Testing for Anemia |
Thrasher Research Fund |
Smart, Luke, TRF |
7/1/2018 - 6/30/2019 |
$18,415 |
| Cristina Tarango, MD |
Community Counts: Public Health Surveillance for Bleeding Disorders |
Hemophilia Foundation of Michigan (Ctr for Disease Control and Prevention) |
U27DD001155 |
9/30/2018 - 9/29/2019 |
$27,250 |
| Cristina Tarango, MD |
Prospective Evaluation of th Duration of Therapy for Thrombosis in Children |
All Childrens Research Inst., Inc. (National Institutes of Health (NIH)) |
U01HL130048 |
7/1/2018 - 6/30/2019 |
$12,748 |
| Cristina Tarango, MD |
Hemophilia and Thrombosis Center |
Hemophilia Foundation of Michigan |
Tarango, CHC,HFM |
6/1/2019 - 5/31/2020 |
$154,257 |
| Cristina Tarango, MD |
ATHN Data Quality Counts |
American Thrombosis & Hemostatis Network |
ATHNROUND10 |
7/1/2018 - 6/30/2019 |
$19,500 |
| Cristina Tarango, MD |
US Cohort Study of Previously Untreated Patients with Congenital Hemophilia |
American Thrombosis & Hemostatis Network |
ATHN2018-ATHN 8 |
1/15/2018 - 12/31/2023 |
$20,750 |
| Cristina Tarango, MD |
2019 Hemophilia Treatment Center |
The Hemophilia Alliance Foundation |
HAF |
4/1/2019 - 3/31/2020 |
$8,000 |
| Russell Ware, MD-PHD |
Endothelialized microfluidics for sickle cell disease research and drug discovery |
Emory University (National Institutes of Health (NIH)) |
T223869 |
1/1/2018 - 12/31/2018 |
$18,374 |
| Russell Ware, MD-PHD |
Realizing Effectiveness Across Continents with Hydroxyurea |
National Institutes of Health (NIH) |
U01HL133883 |
8/1/2018 - 7/31/2019 |
$685,789 |
| Russell Ware, MD-PHD |
Validation of cross-species biomarkers of DNA damage |
Litron Laboratories (National Institutes of Health (NIH)) |
R44ES028163 |
9/1/2018 - 8/31/2019 |
$39,147 |
| Current Year Direct |
$3,569,601 |
